GENESCO INC — fact timeline

Mimi E. Vaughn departed as Interim Chief Financial Officer at GENESCO INC.

“As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s Interim Chief Financial Officer and principal financial officer.”

Jonathan Collins was appointed as Senior Vice President, Finance and Chief Financial Officer at GENESCO INC.

“On June 29, 2026, Genesco Inc. (the “Company”) announced the appointment of Jonathan Collins as Senior Vice President, Finance and Chief Financial Officer.”

GENESCO INC updated its three months ended May 2, 2026 guidance (raised).

“On May 29, 2026, Genesco Inc. issued a press release announcing results of operations for the first fiscal quarter ended May 2, 2026.”

Mimi E. Vaughn changed role as President, Chief Executive Officer, Interim Chief Financial Officer and principal financial officer at GENESCO INC.

“As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s principal accounting officer.”

Ashley Randolph was appointed as Chief Accounting Officer and principal accounting officer at GENESCO INC.

“On May 5, 2026, Genesco Inc. (the “Company”) announced the appointment of Ashley Randolph as Chief Accounting Officer and principal accounting officer.”

GENESCO INC reported the twelve months ended January 31, 2026 results: revenue Net sales of $2.4 billion, EPS GAAP EPS was $1.25 vs. ($1.80) last year and Non-GAAP EPS was $1.45 vs. $0.94 last year.

“Fiscal 2026 Financial Summary • Net sales of $2.4 billion increased 5% compared to FY25 • Comparable sales increased 6%, with stores up 6% and e-commerce up 4% • E-commerce sales represented 25% of retail sales for both this year and last year • Selling and administrative expenses leveraged 120 basis points compared to last year • GAAP EPS was $1.25 vs. ($1.80) last year and Non-GAAP EPS was $1.45 vs. $0.94 last year”

GENESCO INC reported the three and twelve months ended January 31, 2026 results: revenue Net sales of $800 million, EPS GAAP EPS was $4.43 vs. $3.06 last year and Non-GAAP EPS was $3.74 vs. $3.26 last year.

“Genesco Inc. (NYSE: GCO) today reported fourth quarter and full fiscal year results for the three and twelve months ended January 31, 2026. Fourth Quarter Fiscal 2026 Financial Summary • Net sales of $800 million increased 7% compared to Q4FY25 • Comparable sales increased 9%, with stores up 9% and e-commerce up 8% • E-commerce sales represented 31% of retail sales compared to 30% last year • Selling and administrative expenses leveraged 140 basis points compared to last year • GAAP EPS was $4.43 vs. $3.06 last year and Non-GAAP EPS was $3.74 vs. $3.26 last year”

GENESCO INC reported financial results for the fourth fiscal quarter ended January 31, 2026.

“On March 6, 2026, Genesco Inc. issued a press release announcing results of operations for the fourth fiscal quarter ended January 31, 2026.”

GENESCO INC amended Fourth Amendment to Fourth Amended and Restated Credit Agreement with Bank of America, N.A., as agent, and the lenders party thereto (effective 2026-01-16).

“On January 16, 2026, Genesco Inc., a Tennessee corporation (the “ Company ”), entered into a Fourth Amendment to Fourth Amended and Restated Credit Agreement (the “ Fourth Amendment ”) by and among the Company, certain subsidiaries of the Company party thereto (collectively with the Company, the “ Borrowers ”), the lenders party thereto (the “ Lenders ”), and Bank of America, N.A., as agent, amending the Fourth Amended and Restated Credit Agreement, dated as of January 31, 2018 (the “ Credit Agreement ”), by and among the Borrowers, the Lenders party thereto and Bank of America, N.A., as Agent.”

GENESCO INC engaged Deloitte & Touche LLP as its auditor.

“approved (1) the dismissal of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm, and (2) the appointment of Deloitte & Touche LLP (“Deloitte”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2026”

GENESCO INC dismissed Ernst & Young LLP as its auditor.

“approved (1) the dismissal of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm, and (2) the appointment of Deloitte & Touche LLP (“Deloitte”) to serve as the Company’s independent registered public accounting firm for the fiscal year ending January 31, 2026”

Thomas A. George retired as Senior Vice President, Finance and Chief Financial Officer at GENESCO INC.

“On October 1, 2024, the Company also announced that Thomas A. George, Senior Vice President, Finance and Chief Financial Officer, will be leaving the Company as part of his planned retirement.”

Cassandra "Sandra" Harris was appointed as Senior Vice President, Finance and Chief Financial Officer at GENESCO INC.

“On October 1, 2024, Genesco Inc. (the “Company”) announced the appointment of Cassandra “Sandra” Harris as Senior Vice President, Finance and Chief Financial Officer of the Company, effective October 7, 2024”

Brently G. Baxter departed as vice president and chief accounting officer at GENESCO INC.

“on June 27, 2024, Brently G. Baxter notified the Company that he will resign as the Company’s vice president and chief accounting officer effective July 31, 2024.”

Thomas A. George was appointed as chief financial officer and senior vice president – finance at GENESCO INC.

“On June 27, 2024, Thomas A. George, Genesco Inc.’s (the “Company”) chief financial officer and senior vice president – finance, was appointed to serve in the additional role of the Company’s principal accounting officer”

GENESCO INC shareholders approved Advisory vote on the frequency of future shareholder advisory votes on executive compensation at the 2023-06-26 meeting.

“the Company reported in its Initial Filing that a majority of the Company’s shareholders cast a non‐binding, advisory vote for an annual frequency for future shareholder advisory votes on the Company’s executive compensation”

GENESCO INC reported fourth fiscal quarter and year ended February 3, 2024 results: revenue $739 million, EPS $1.84.

“today reported fourth quarter and full fiscal year results for the three and twelve months ended February 3, 2024. Fourth Quarter Fiscal 2024 Financial Summary • Net sales of $739 million this year (14 weeks) increased 2% compared to Q4FY23 (13 weeks) • Comps down 4%, with stores down 7% and direct up 5% • E-commerce sales represented 27% of retail sales compared”

GENESCO INC reported the third fiscal quarter ended October 28, 2023 results: revenue Net sales of $579 million, net income GAAP earnings from continuing operations were $6.6 million, EPS GAAP EPS from continuing operations was $0.60.

“1, 2023 --- Genesco Inc. (NYSE: GCO) today reported third quarter results for the three months ended October 28, 2023. Third Quarter Fiscal 2024 Financial Summary • Net sales of $579 million decreased 4% compared to Q3FY23 • Comps down 4%, with stores down 7% and direct up 8% • E-commerce sales represented 21% of retail sales compared to 18% last year • GAAP EPS from”

Andrew I. Gray was appointed as President, Journeys Group and Senior Vice President at GENESCO INC.

“On November 28, 2023, Genesco Inc. (the “Company”) announced that Andrew I. Gray has been named President, Journeys Group and Senior Vice President of the Company, effective January 3, 2024 (the “Effective Date”).”

GENESCO INC reported second fiscal quarter ended July 29, 2023 results: net income adjusted loss from continuing operations was ($9.6) million, EPS Non-GAAP EPS from continuing operations was ($0.85). Guidance reaffirmed.

“Adjusted for the Excluded Items in all periods, the second quarter loss from continuing operations was ($9.6) million, or ($0.85) per share, in Fiscal 2024”

Mario Gallione departed as President of Journeys and Senior Vice President at GENESCO INC.

“On August 30, 2023, Genesco Inc. (the “Company”) announced the upcoming retirement of Mario Gallione, President of Journeys and Senior Vice President, with an expected effective date of February 3, 2024.”

GENESCO INC shareholders approved Ratification of Independent Accountants at the 2023-06-22 meeting.

“Ratification of Independent Accountants The Company’s shareholders voted upon and approved the ratification of the appointment of Ernst & Young LLP to serve as the Company’s independent registered public accounting firm for the current fiscal year. The votes on this proposal were as follows: For Against Abstain 10,358,359 264,467 10,811”

GENESCO INC shareholders approved Approval of the Genesco Inc. Amended and Restated 2020 Equity Incentive Plan at the 2023-06-22 meeting.

“Approval of the Genesco Inc. Amended and Restated 2020 Equity Incentive Plan The Company's shareholders voted upon and approved the Genesco Inc. Amended and Restated 2020 Equity Incentive Plan as disclosed in the proxy statement for the Annual Meeting. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 9,291,921 824,831 10,932 505,953”

GENESCO INC shareholders approved Non-Binding, Advisory Vote on the Desired Frequency of Advisory Votes on Executive Compensation at the 2023-06-22 meeting.

“Non-Binding, Advisory Vote on the Desired Frequency of Advisory Votes on Executive Compensation The Company’s shareholders voted upon a non-binding, advisory proposal to approve the desired frequency of future votes on executive compensation. The votes on this proposal were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 9,145,907 22,836 954,476 4,465 505,953”

GENESCO INC shareholders approved Non-Binding, Advisory Vote on the Company’s Executive Compensation at the 2023-06-22 meeting.

“Non-Binding, Advisory Vote on the Company’s Executive Compensation The Company’s shareholders voted upon a non‐binding, advisory proposal to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement for the Annual Meeting. The votes on this proposal were as follows: For Against Abstain Broker Non-Votes 8,961,043 1,152,689 13,952 505,953”

GENESCO INC shareholders approved Election of directors at the 2023-06-22 meeting.

“Election of Directors The Company’s shareholders elected all nine persons nominated for election as directors until the next annual meeting of the shareholders and until their successors are elected and qualified as set forth in the Company’s proxy statement dated May 12, 2023. The following table sets forth the vote of the shareholders at the Annual Meeting with respect to the election of directors: Nominee For Against Abstain Broker Non-Votes Joanna Barsh 8,845,688 1,263,996 18,000 505,953 Matthew M. Bilunas 10,047,844 61,690 18,150 505,953 Carolyn Bojanowski 10,046,354 63,330 18,000 505,953 John F. Lambros 9,570,891 538,703 18,090 505,953 Thurgood Marshall, Jr. 9,463,066 650,102 14,516 505,953 Angel R. Martinez 10,030,338 79,156 18,190 505,953 Mary E. Meixelsperger 9,997,059 112,625 18,000 505,953 Gregory A. Sandfort 9,608,937 500,612 18,135 505,953 Mimi E. Vaughn 9,442,978 664,807 19,899 505,953”

GENESCO INC reported the three months ended April 29, 2023 results: revenue $483 million, net income ($18.9) million, EPS ($1.60). Guidance lowered.

“25, 2023 --- Genesco Inc. (NYSE: GCO) today reported first quarter results for the three months ended April 29, 2023. First Quarter Fiscal 2024 Financial Summary • Net sales of $483 million decreased 7% compared to Q1FY23 • Excluding the impact of lower exchange rates, net sales decreased 6% compared to Q1FY23 • Comps down 5%, with stores down 8% and direct up 7% •”

GENESCO INC reported the fourth fiscal quarter and year ended January 28, 2023 results: revenue Net sales of $725 million, EPS GAAP EPS from continuing operations was $3.23. Guidance lowered.

“Genesco Inc. (NYSE: GCO) today reported fourth quarter and full fiscal year results for the three and twelve months ended January 28, 2023. Fourth Quarter Fiscal 2023 Financial Summary • Net sales of $725 million were essentially flat with last year and increased 7% over Q4FY20”

GENESCO INC reported Fiscal year 2023 results: EPS $5.50 to $5.90. Guidance lowered.

“we now expect adjusted earnings per share for Fiscal 2023 to range between $5.50 to $5.90.”

Kevin McDermott departed as Director at GENESCO INC.

“Matthew C. Diamond and Kevin McDermott notified the Board on November 21, 2022 of their decisions to retire and not stand for re-election at the 2023 Annual Meeting.”

Matthew C. Diamond departed as Director at GENESCO INC.

“Matthew C. Diamond and Kevin McDermott notified the Board on November 21, 2022 of their decisions to retire and not stand for re-election at the 2023 Annual Meeting.”

Carolyn Bojanowski was appointed as Director at GENESCO INC.

“approved an increase in the size of the Board from nine to eleven directors effective January 29, 2023, the first day of the Company’s 2024 fiscal year, and appointed Matt Bilunas and Carolyn Bojanowski to fill the resulting vacancies”

Matt Bilunas was appointed as Director at GENESCO INC.

“approved an increase in the size of the Board from nine to eleven directors effective January 29, 2023, the first day of the Company’s 2024 fiscal year, and appointed Matt Bilunas and Carolyn Bojanowski to fill the resulting vacancies”

GENESCO INC: Amended bylaws to require compliance with Rule 14a-19 for director nominations, clarify consent requirements, limit number of nominees, allow disregarding non-compliant proxies, and require non-white proxy cards for shareholder solicitors (effective 2022-10-27).

“On October 27, 2022, the board of directors of Genesco, Inc. (the "Company") approved Second Amended and Restated Bylaws for the Company (the "Second Amended and Restated Bylaws"), effective immediately to: Director Nominations - Article II, Section 6 • Require that, to propose a nominee for election as a director at a meeting of the shareholders, a proposing shareholder must fully comply with Rule 14a-19 under the Securities Exchange Act of 1934, as amended ("Rule 14a-19"), including with respect to the solicitation of proxies;”

Thomas A. George was named as Senior Vice President, Finance and Chief Financial Officer at GENESCO INC.

“On October 21, 2021, Genesco Inc. (the “Company”) announced that Thomas A. George has been named Senior Vice President, Finance and Chief Financial Officer of the Company, effective immediately.”